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Abstract
Introduction: Adrenal myelolipomas are relatively rare, non-functioning benign tumours composed
of mature fatty and active hematopoietic elements. They can be asymptomatic, even if their size is
massive. Diagnosis is relatively simple using ultrasound, computed tomography and magnetic
resonance imaging. Surgical resection through an extraperitoneal approach is advocated in cases of
symptomatic or large myelolipomas exceeding 5-cm in diameter. Their low incidence seems to be
increasing from 0.2% to 10% during the last decade.
Case presentation: We present a case of a giant adrenal myelolipoma in a 68-year-old Caucasian
male, who was presented with left lumbar pain. Renal ultrasound, CT and MRI demonstrated a well
demarcated mass, with a maximum diameter of 10-cm. The differential diagnosis comprised the
adrenal myelolipoma, the retroperitoneal liposarcoma and the renal angiomyolipoma. Thus, the
patient was subjected to a left adrenalectomy.
Conclusion: Multiple theories have been proposed for the increasing frequency and natural course
of the adrenal myelolipoma, with chronic adrenal stimulation and the contemporary stressful lifestyle
to be the most appealing. Surgical treatment is advocated through an extraperitoneal approach
because of the quicker recovery of the patient and the smaller postoperative complication rate.
Introduction
Adrenal myelolipoma is an uncommon urological entity,
which has an increasing incidence. Despite its benign
biology, when presented as a giant tumor, the urologist can
face diagnostic dilemmas or even an acute clinical setting.
We present a case of an asymptomatic giant adrenal
myelolipoma, one of the largest reported in the literature
and discuss issues concerning the diagnosis, the
management and the proposed theories for the increased
prevalence of this lesion.
Case presentation
A68-year-oldCaucasianmale,with history of untreated left
nephrolithiasis, was presented to our hospital, complain-
ing of left lumbar pain, typical of a left renal colic. During
the kidney ultrasound, a large, well demarcated mass, with
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a maximum diameter of 10-cm was demonstrated, in the
upper pole of the right kidney, mimicking a renal
angiomyolipoma. Contrast-enhanced computed tomo-
graphy (CT) was performed the next day, verifying a
heterogeneous mass with predominant fatty components
in the right retroperitoneal space,measuring approximately
12-cm in diameter, slightly compressing the right kidney
and vena cava (Figure 1a). Magnetic resonance imaging
(MRI) was performed and the findings were classic for
myelolipoma (Figure 1b). The tumour was predominantly
hyperintense with signal intensity similar to fat on T1/T2-
weighted images and lost signal on the fat-suppressed
sequences. No other pathological findings were recorded,
apart from a large lower pole calculus of the left kidney,
with a diameter of 1.4-cm, evidential of the patient’s
nephrolithiasis. The differential diagnosis comprised the
adrenalmyelolipoma, the retroperitoneal liposarcoma and
the renal angiomyolipoma.
Surgery was performed through a right subcostal incision
for the extraperitoneal approach of the right adrenal gland.
The mass was totally dissected from the upper pole of the
right kidney and excised en-block with the right adrenal
gland. The macroscopic examination of the mass revealed
a giant mass measuring 19 × 12 × 2 cm, surrounded by a
thin capsule. Yellow adipose tissue was unevenly scattered
on the capsule with varying amounts of red hematopoietic
tissue (Figure 2). The pathology report showed a giant
myelolipoma of the right adrenal gland.
The patient had an uneventful postoperative course and
was discharged on postoperative day 4.
Discussion
Adrenal myelolipomas are also called incidentalomas, since
their diagnosis is based on autopsy or imaging techniques
performed for reasons unrelated to adrenal diseases. They
are relatively rare, non-functioning benign tumors com-
posed of mature fatty and active hematopoietic elements.
Their incidence ranges from 0.01% to 0.2% and less than
300 cases were reported until 2000 [1]. Nevertheless, their
prevalence seems to be increasing up to 10%, due to novel
and enhanced imaging techniques [2]. Is this however the
only reason for this increase?
Multiple theories have been proposed for the aetiology
and natural course of the adrenal myelolipoma [3-5]. The
most widely accepted theory is adrenocortical cell meta-
plasia in response to stimuli, such as necrosis, inflamma-
tion, infection or stress [6]. The chronic adrenal
stimulation, as it is demonstrated by the high incidence
of the disease to the elderly [7], could generate the
development of benign or malignant tumors. Cushing’s
disease, hypertension, diabetes and obesity are often
related to adrenal myelolipomas and could be character-
ized as major adrenal stimuli. We could also speculate that
the contemporary stressful lifestyle and imbalanced diet
could be implicated to the pathogenesis of this tumour.
Another unusual and unexplained observation is the
predominance of the tumour in the right adrenal gland,
as reported in several series [8].
Diagnosis of adrenal myelolipomas can be unproblematic
with the use of ultrasound, contrast-enhanced CT, MRI or
positron emission tomography (PET). We believe that fine-
needle aspiration bears the risk of rupture, especially in cases
of giant lesions and spillage when a malignant neoplasia is
encountered. No endocrinological evaluation is needed,
since myelolipomas are non-functioning tumours.
The management of adrenal myelolipomas should be
individualized. A small, less than 5-cm, asymptomatic
myelolipoma could be followed-up over a 1-2 year period
with imaging controls. On the contrary, a symptomatic
lesion or a large >5-cm myelolipoma should be surgically
excised, since there are reports of spontaneous rupture and
Figure 1. (a) Enhanced computed tomography (CT) of the
upper abdomen, showing a large heterogenous mass, covering
the upper right retroperitoneal space, (b) Magnetic resonance
imaging (MRI) of the mass, which demonstrates clearly the
origin of the mass from the adrenal gland. The right kidney is
slightly deviated.
Figure 2. (a) Myelolipoma attached to the adrenal gland
(H & E stain, ×25), (b) Typical hstological features of
myelolipoma comprising adipose tissue and poorly
differentiated plasma cells with large, hyperchromatic nuclei
(H & E stain, ×100).
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haemorrhage of the mass presented with life-threatening
cardiovascular shock [9]. We prefer the extraperitoneal
approach rather than a midline incision, because of the
quicker recovery of the patient and the smaller post-
operative complication rate. The laparoscopic approach
seems to be gaining ground on themanagement of adrenal
tumours.On theother hand, this procedure is not indicated
for masses larger than 10-cm or including adhesions and
infiltration of the surrounding structures [10].
Conclusion
The adrenal myelolipoma is a rare urological entity, which
seems to increase its frequency, probably due to causes
affecting primarily the function and physiology of the
adrenals. Our case described one of the largest ever
reported myelolipomas, which despite its size, can be
rather asymptomatic. However, even with the contempor-
ary imaging modalities, precise diagnosis is difficult. Thus,
we advocate open surgical management, since a laparo-
scopic approach might be extremely complicated in cases
of such large tumours.
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